Article ID Journal Published Year Pages File Type
9925271 The American Journal of Geriatric Pharmacotherapy 2005 12 Pages PDF
Abstract
In the current study, rivastigmine treatment for 26 weeks in nursing home residents with moderate to severe probable AD was associated with decreased NPI-NH item scores for a wide range of behavioral disturbances in the subgroup of patients with behavioral symptoms at baseline.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Geriatrics and Gerontology
Preview
Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study
Authors
, , , , ,